Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Skin Diseases and Disorders01:23

Skin Diseases and Disorders

Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[The psoriasis--metabolic syndrome comorbidity, a complex multigenic disease].

Revue medicale de Liege·2012
Same author

[Staphylococcus and its counter-measures against epidermal antimicrobial peptides].

Revue medicale de Liege·2012
Same author

[Drug-related psoriasis].

Revue medicale de Liege·2012
Same author

[The thousand and one facets of skin stem cells. The future has found new roots].

Revue medicale de Liege·2012
Same author

[Metastatic melanoma: some hope from ipilimumab and vemurafenib].

Revue medicale de Liege·2012
Same author

[A pin-point pattern of rapid occurrence on the skin of adolescents].

Revue medicale de Liege·2012

Related Experiment Video

Updated: May 17, 2026

A 3D Organotypic Melanoma Spheroid Skin Model
08:49

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

[Cutaneous malignant melanoma: one single disease ?].

G E Piérard1, C Piérard-Franchimont, T Hermanns-Lê

  • 1Université de Liège et Besançon, France.

Revue Medicale De Liege
|November 3, 2012
PubMed
Summary

Malignant melanoma, a dreaded skin cancer, is not a single disease. Different melanoma types have unique origins and prognoses, requiring individualized patient management and information.

Area of Science:

  • Oncology
  • Dermatology
  • Pathology

Context:

  • Malignant melanoma is widely perceived as a singular, severe skin cancer.
  • Public and media understanding often overlooks the heterogeneity of this disease.

Purpose:

  • To highlight the distinct pathological subtypes of malignant melanoma.
  • To emphasize the importance of personalized treatment strategies based on melanoma type.

Summary:

  • Clinical presentation, histopathology, and molecular genetics reveal that malignant melanoma comprises diverse subtypes.
  • These subtypes originate differently and possess distinct prognostic trajectories.
  • Recognizing these differences is crucial for effective patient care.

Impact:

More Related Videos

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
06:09

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

Pharmacologic Induction of Epidermal Melanin and Protection Against Sunburn in a Humanized Mouse Model
12:37

Pharmacologic Induction of Epidermal Melanin and Protection Against Sunburn in a Humanized Mouse Model

Published on: September 7, 2013

Related Experiment Videos

Last Updated: May 17, 2026

A 3D Organotypic Melanoma Spheroid Skin Model
08:49

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
06:09

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

Pharmacologic Induction of Epidermal Melanin and Protection Against Sunburn in a Humanized Mouse Model
12:37

Pharmacologic Induction of Epidermal Melanin and Protection Against Sunburn in a Humanized Mouse Model

Published on: September 7, 2013

  • Promotes a more nuanced understanding of malignant melanoma beyond a monolithic view.
  • Advocates for tailored management plans and patient education specific to individual melanoma types.
  • Improves potential patient outcomes through personalized oncological and dermatological approaches.